BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35893848)

  • 21. Comparing Apoptosis and Necrosis Effects of Arctium Lappa Root Extract and Doxorubicin on MCF7 and MDA-MB-231 Cell Lines.
    Ghafari F; Rajabi MR; Mazoochi T; Taghizadeh M; Nikzad H; Atlasi MA; Taherian A
    Asian Pac J Cancer Prev; 2017 Mar; 18(3):795-802. PubMed ID: 28441789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anatolian honey is not only sweet but can also protect from breast cancer: Elixir for women from artemis to present.
    Seyhan MF; Yılmaz E; Timirci-Kahraman Ö; Saygılı N; Kısakesen Hİ; Eronat AP; Ceviz AB; Bilgiç Gazioğlu S; Yılmaz-Aydoğan H; Öztürk O
    IUBMB Life; 2017 Sep; 69(9):677-688. PubMed ID: 28695656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative CK19 biomarker detection in breast cancer cell lines.
    Orafa Z; Karimi N; Keyvani S; Oloomi M
    J Med Life; 2022 Feb; 15(2):188-195. PubMed ID: 35419102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.
    Marchese S; Silva E
    PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis.
    Rondón-Lagos M; Verdun Di Cantogno L; Marchiò C; Rangel N; Payan-Gomez C; Gugliotta P; Botta C; Bussolati G; Ramírez-Clavijo SR; Pasini B; Sapino A
    Mol Cytogenet; 2014 Jan; 7(1):8. PubMed ID: 24456987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Study of Lipophilic Statin Activity in 2D and 3D in vitro Models of Human Breast Cancer Cell Lines MDA-MB-231 and MCF-7.
    Bytautaite M; Petrikaite V
    Onco Targets Ther; 2020; 13():13201-13209. PubMed ID: 33380809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Petroselinum Crispum on Estrogen Receptor-positive Benign and Malignant Mammary Cells (MCF12A/MCF7).
    Schröder L; Koch J; Mahner S; Kost BP; Hofmann S; Jeschke U; Haumann J; Schmedt J; Richter DU
    Anticancer Res; 2017 Jan; 37(1):95-102. PubMed ID: 28011479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
    Somers-Edgar TJ; Rosengren RJ
    Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).
    Takabatake D; Fujita T; Shien T; Kawasaki K; Taira N; Yoshitomi S; Takahashi H; Ishibe Y; Ogasawara Y; Doihara H
    Int J Cancer; 2007 Jan; 120(1):181-8. PubMed ID: 17036319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA.
    Lin VC; Jin R; Tan PH; Aw SE; Woon CT; Bay BH
    Am J Pathol; 2003 Jun; 162(6):1781-7. PubMed ID: 12759236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
    Tanaka S; Suzuki K; Sakaguchi M
    Breast Cancer; 2017 Sep; 24(5):658-666. PubMed ID: 28070831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells.
    Yousefnia S; Naseri D; Seyed Forootan F; Tabatabaeian M; Moattar F; Ghafghazi T; Nasr Esfahani MH; Ghaedi K
    Clin Transl Oncol; 2020 Sep; 22(9):1619-1634. PubMed ID: 32056127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.
    Wang F; Hansen RK; Radisky D; Yoneda T; Barcellos-Hoff MH; Petersen OW; Turley EA; Bissell MJ
    J Natl Cancer Inst; 2002 Oct; 94(19):1494-503. PubMed ID: 12359858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development.
    Ekert JE; Johnson K; Strake B; Pardinas J; Jarantow S; Perkinson R; Colter DC
    PLoS One; 2014; 9(3):e92248. PubMed ID: 24638075
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Banerjee PP; Bandyopadhyay A; Harsha SN; Policegoudra RS; Bhattacharya S; Karak N; Chattopadhyay A
    Breast Cancer (Dove Med Press); 2017; 9():265-278. PubMed ID: 28458579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.
    Feng H; Ou BC; Zhao JK; Yin S; Lu AG; Oechsle E; Thasler WE
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1771-1786. PubMed ID: 28497169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrahigh-throughput Generation and Characterization of Cellular Aggregates in Laser-ablated Microwells of Poly(dimethylsiloxane).
    Albritton JL; Roybal JD; Paulsen SJ; Calafat N; Flores-Zaher JA; Farach-Carson MC; Gibbons DL; Miller JS
    RSC Adv; 2016 Jan; 6(11):8980-8991. PubMed ID: 26998251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
    Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
    Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry.
    Radhika K; Prayaga AK
    Indian J Cancer; 2010; 47(2):148-50. PubMed ID: 20448377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.